NCODA shared a post on LinkedIn:
“Coming Up This Week at NCODA
Tue, Aug 19 | 2 p.m. EST
Dr. John Renshaw (Texas Oncology) will share practical strategies for supporting veterans with CLL and approaches for safely and effectively integrating zanubrutinib into treatment plans.
Wed, Aug 20 | 2 p.m. and 5 p.m. EST
Jessica Freydman, PharmD, BCOP (Massachusetts General Hospital), will provide a pharmacist’s perspective on emerging AML trends, therapeutic advances, and evolving treatment approaches in our disease education series.
Thu, Aug 21 | 2 p.m. EST
The NCODA International Monthly Webinar will address oncology policy and legislative changes that could impact care delivery, best practices for optimizing taletrectinib in ROS1+ NSCLC, and new isatuximab trial findings with discussion on the potential role of an investigational on-body injector in multiple myeloma.
See all upcoming webinars.”
More posts featuring NCODA on OncoDaily.